InsiderClue
← All stocks

BridgeBio Pharma, Inc.

BBIO Net selling
CIK 0001743881 #743 in the set updated 17 Sep 2026
Bought (120 mo)
$210.30M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.44B
$160.91M on a plan · $57.95M straight out of an exercise
Sold at will
$1.22B
146 of 428 sales
Net
−$1.23B
−$1.01B against sales at will

By person

28 insiders · 454 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
KKR Genetic Disorder L.P.
10% owner
$45.00M (1)
$840.72M (5)
−$795.72M
13,260,971
6.78%
$1.14B
—
VIKING GLOBAL INVESTORS LP entity
10% owner
$80.00M (1)
$313.49M (3)
−$233.49M
18,555,375
9.49%
$1.59B
—
Kumar Neil
Chief Executive Officer
—
$148.80M (214) scheduled
−$148.80M
749,013
0.3832%
$64.15M
—
VIKING GLOBAL PERFORMANCE LLC entity
10% owner
$80.00M (1)
—
+$80.00M
26,620,991
13.62%
$2.28B
—
MCCORMICK FRANK
Director
—
$33.91M (22) scheduled
−$33.91M
690,558
0.3532%
$59.15M
—
Cook Jennifer E.
Director
—
$21.92M (6) scheduled
−$21.92M
8,383
0.0043%
$718.00K
—
HOMCY CHARLES J
Director
—
$19.45M (10) scheduled
−$19.45M
919,876
0.4706%
$78.79M
+11,522%
Lo Andrew
Director
$98.85K (2)
$10.17M (5)
−$10.07M
68,662
0.0351%
$5.88M
−72.1%
STEPHENSON BRIAN C
CFO and Treasurer
$1.44M (2)
$11.31M (47) scheduled
−$9.87M
102,464
0.0524%
$8.78M
+2,112%
SCHELLER RICHARD H
Director
—
$9.47M (8)
−$9.47M
53,822
0.0275%
$4.61M
—
Ellis Andrea
Director
$100.68K (1)
$7.87M (5) scheduled
−$7.77M
22,579
0.0116%
$1.93M
—
Trimarchi Thomas
President and CFO
—
$5.99M (9) scheduled
−$5.99M
336,529
0.1721%
$28.82M
−14.8%
Valantine Hannah
Director
$69.58K (3)
$5.58M (16) scheduled
−$5.51M
9,657
0.0049%
$827.12K
+1,132%
DANIELS RONALD J
Director
$298.68K (2)
$4.04M (2) scheduled
−$3.74M
20,981
0.0107%
$1.80M
—
HENDERSON MICHAEL THOMAS
Chief Business Officer
$119.00K (1)
$3.75M (35) scheduled
−$3.64M
274,211
0.1403%
$23.49M
+17,299%
Turtle Cameron
See Remarks
—
$3.63M (17) scheduled
−$3.63M
12,568
0.0064%
$1.08M
—
Scott Randal W.
Director
$1.00M (1)
$2.48M (17) scheduled
−$1.48M
15,589
0.0080%
$1.34M
+211.8%
MOMTAZEE JAMES C
Director
$1.16M (1)
—
+$1.16M
19,070
0.0098%
$1.63M
—
Apuli Maricel
Chief Accounting Officer
—
$706.65K (7) scheduled
−$706.65K
122,687
0.0628%
$10.51M
−2.3%
Hassan Fred
Director
$273.39K (1)
—
+$273.39K
29,879
0.0153%
$2.56M
—
SAUNDERS BRENT L
Director
$254.88K (1)
—
+$254.88K
17,600
0.0090%
$1.51M
—
Dachille Douglas A.
Director
$245.58K (3)
—
+$245.58K
30,579
0.0156%
$2.62M
—
Sinha Uma
Chief Scientific Officer
$238.00K (1)
—
+$238.00K
16,460
0.0084%
$1.41M
—
Satvat Ali J.
Director
—
—
—
169,983
0.0870%
$14.56M
—
Stolz Brian M.
Chief Operating Officer
—
—
—
24,615
0.0126%
$2.11M
+3,258%
AGUIAR ERIC
Director
—
—
—
10,579
0.0054%
$906.09K
—
YAU YI CHING
Chief Accounting Officer
—
—
—
4,586
0.0023%
$392.79K
+525.6%
KKR Management Holdings L.P. entity
10% owner
—
—
—
0
0.0000%
$0.00
−100.0%

Individual transactions

34
Insider
Date
Role
Action
Shares
Price
Amount
Cook Jennifer E.
9 Jul 2026
Director
Sold after exercise
112,422
$90.00
$10.12M
Cook Jennifer E.
9 Jul 2026
Director
Sold after exercise
36,167
$84.00
$3.04M
Ellis Andrea
9 Jul 2026
Director
Sold after exercise
17,167
$84.00
$1.44M
Cook Jennifer E.
24 Jun 2026
Director
Sold after exercise
37,167
$70.00
$2.60M
Valantine Hannah
22 Jun 2026
Director
Sold after exercise
2,808
$68.00
$190.94K
Cook Jennifer E.
15 Jun 2026
Director
Sold after exercise
1,503
$67.14
$100.92K
Cook Jennifer E.
15 Jun 2026
Director
Sold after exercise
88,737
$66.62
$5.91M
Scott Randal W.
15 May 2026
Director
Sold after exercise
200
$69.12
$13.82K
Scott Randal W.
15 May 2026
Director
Sold after exercise
1,512
$68.23
$103.16K
Scott Randal W.
15 May 2026
Director
Sold after exercise
2,088
$67.53
$141.00K
Scott Randal W.
15 May 2026
Director
Sold after exercise
6,200
$66.69
$413.46K
Valantine Hannah
10 Mar 2026
Director
Sold after exercise
8,671
$72.00
$624.31K
Ellis Andrea
4 Mar 2026
Director
Sold after exercise
64,921
$64.87
$4.21M
Valantine Hannah
27 Feb 2026
Director
Sold after exercise
10,900
$67.84
$739.50K
Valantine Hannah
27 Feb 2026
Director
Sold after exercise
14,584
$67.08
$978.28K
Scott Randal W.
17 Feb 2026
Director
Sold after exercise
3,307
$75.93
$251.09K
Scott Randal W.
17 Feb 2026
Director
Sold after exercise
4,793
$75.57
$362.22K
Scott Randal W.
17 Feb 2026
Director
Sold after exercise
1,900
$74.34
$141.25K
Scott Randal W.
17 Nov 2025
Director
Sold after exercise
6,199
$66.89
$414.66K
Scott Randal W.
17 Nov 2025
Director
Sold after exercise
3,801
$66.25
$251.81K
Valantine Hannah
12 Nov 2025
Director
Sold after exercise
25,484
$66.07
$1.68M
DANIELS RONALD J
6 Nov 2025
Director
Sold after exercise
61,031
$63.72
$3.89M
MCCORMICK FRANK
5 Sep 2025
Director
Sold after exercise
74,000
$53.16
$3.93M
Ellis Andrea
5 Aug 2025
Director
Sold after exercise
17,167
$49.00
$841.18K
Valantine Hannah
10 Jun 2025
Director
Sold after exercise
4,292
$40.00
$171.68K
Ellis Andrea
14 Apr 2025
Director
Sold after exercise
10,000
$35.00
$350.00K
Ellis Andrea
1 Apr 2025
Director
Sold after exercise
30,000
$34.05
$1.02M
Valantine Hannah
6 Mar 2025
Director
Sold after exercise
12,875
$32.58
$419.50K
STEPHENSON BRIAN C
25 Feb 2025
CFO and Treasurer
Sold after exercise
100
$34.18
$3.42K
STEPHENSON BRIAN C
25 Feb 2025
CFO and Treasurer
Sold after exercise
8,400
$33.18
$278.70K
STEPHENSON BRIAN C
28 Jan 2025
Secretary, Treasurer & CFO
Sold after exercise
68,000
$36.29
$2.47M
Valantine Hannah
15 Feb 2024
Director
Sold after exercise
2,915
$37.75
$110.04K
Valantine Hannah
16 Jan 2024
Director
Sold after exercise
2,915
$37.97
$110.68K
Valantine Hannah
15 Dec 2023
Director
Sold after exercise
2,915
$36.12
$105.29K
Showing 250 of 454 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 400
Amendments (4/A) skipped 5
Filings about a different issuer 8
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 209
Sales straight out of an exercise 73
Sales at will 146
Transactions with no price 1
Shares from compensation/vesting 141,557,600
Sales filed before the plan box existed 128
History held since 26 Jun 2018